Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-07-29
1998-05-05
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 47, 536 2613, 536 2762, A61K 3170
Patent
active
057474745
ABSTRACT:
Methods for inducing immunosuppression in animals which need immunosuppressive treatment involving administration to animals of a therapeutically effective amount of the cyclic AMP agent HE-33 or its nucleoside.
REFERENCES:
patent: 4309419 (1982-01-01), Wolberg et al.
patent: 4369181 (1983-01-01), Miller et al.
patent: 4861873 (1989-08-01), Robins et al.
patent: 4873227 (1989-10-01), Ikada et al.
patent: 5246922 (1993-09-01), Kataoka et al.
patent: 5364862 (1994-11-01), Spada et al.
patent: 5561134 (1996-10-01), Spada et al.
Kataoka et al. (II), "Studies on the Synthesis of Compounds Related to Adenosine 3', 5'-Cyclic Phosphate. VII. Synthesis and Cardiac Effects of N.sup.6, N.sup.6 -Dialkyl Adenosine 3'5'-Cyclic Phosphates," Chem. Pharm. Bull., 38(11), 3147-3154 (Nov. 1990).
Allen et al., "Enhamcement of Interfereon Antiviral Action in L-Cells by Cyclic Nucleotides," Proc. Soc. Exp. Biol. Med., 146(2), 580-584 (1974); Chem. Abstr., 82(9), p. 75, Abstr. No. 51914b (Mar. 3, 1975); only abstract supplied.
Hayashi et al., "Regulation of Steroidogenesis by Adrenocorticotropic Hormone in Isolated Adrenal Cells," J. Biol. Chem., 254(14), 6678-6683 (Jul. 25, 1979).
Cheitlin et al., "The Role of Extracellular Calcium in Corticotropin-Stimulated Steroidogenesis," J. Biol. Chem., 260(9), 5323-5327 (May 10, 1985).
Carsia et al.(I), "Ontogenic Corticosteroidogenesis of the Domestic Fowl: Response of Isolated Adrenocortical Cells," Proc. Soc. Expl. Biol. Med., 184(4), 436-445 (Apr. 1987).
Carsia et al.(II), "Effect of 3,3'-Iminodiproprionitrile (IDPN) on Corticosteroidogenesis of Isolated Adrenocortical Cells,", Proc. Soc. Expl. Biol. Med., 184(4), 461-467 (Apr. 1987).
Ray et al., "Activation of the Human ".beta..sub.2 -Interferon/Hepatocyte-Stimulating Factor/Interleukin 6 Promoter by Cytokines, Viruses, and Second Messenger Agonists, Proc. Nat. Acad. Sci. USA, 85, 6701-6705 (Sep. 1988).
Misaki et al., "Effects of Rat .gamma.-and Non-.gamma.-Interferons on the Expression of Ia Antigen, Growth, and Differentiated Functions of FRTL5 Cells," Endocrinology, 123(6), 2849-2857 (Dec. 1988).
Kone et al., "Role of NF-.kappa.B in the Regulation of Inducible Nitric Oxide Synthase in an MTAL Cell Line," Am. J. Physiology: Renal, Fluid and Electrolyte Physiology, 38(5), F718-F729 (Nov. 1995).
Matsumori et al., "Inotropic Agents Differentially Inhibit the Induction of Nitric Oxide Synthase by Endotoxin in Cultured Macrophages," Life Sciences Including Pharmacology Letters, 59(10), PL121-PL125 (Aug. 2, 1996).
Ragsdale et al., "Loss of Fc Receptor Activity After Culture of Human Monocytes on Surface-Bound Immune Complexes," J. Exp. Medicine, 151(1), 32-44 (Jan. 1980).
Tutton et al., "Effects of Cyclic-Nucleotide Derivatives on the Growth of Human Colonic Carcinoma Xenografts and on Cell Production in the Rate Colonic Crypt Epithelium," British J. Cancer, 44(2), 182-188 (Aug. 1981).
Calkins et al., "Interleukin-1 Inhibits Leydig Cell Steriodogenesis in Primary Culture," Endocrinology, 123(3), 1605-1610 (Sep. 1988).
Ramage et al., "Growth Inhibition by 8-Chloro Cyclic AMP of Human HT29 Colorectal and ZR-75-1 Breast Carcinoma Zenografts is Associated with Selective Modulation of Protein Kinase A Isozymes," European J. Cancer, 31A(6), 969-973 (1995).
Nichols et al., "Induction of Ornithine Decarboxylase in Macrophages by Bacterial Liposaccharides (LPS) and Mycobacterial Cell Wall Material," Life Sciences, 27(11), 913-920 (Sep. 15, 1980).
Golos et al., "Regulation of Low Density Lipoprotein Receptor Synthesis in Cultured Luetinized Human Granulosa Cells by Human Chorionic Gonadotropin and 8-Bromo-cyclic AMP," J. Biol. Chem., 260(27), 14399-14402 (Nov. 25, 1985).
Knepel et al., "Effect of Prostaglandin E.sub.2 on ACTH and .beta.-Endorphin Release from Rat Adenohypophysis in vitro After Secretagogues Which Can Mimic Various First or Second Messangers," Naunyn-Schmiedeberg's Arch. Pharmacology, 333(2), 149-155 (Jun. 1986).
Yamashita et al., "Regulation of Human Growth Hormone Gene Expression by Insulin-like Growth Factor I in Transfected Cells," J. Biol. Chem., 262(27), 13254-13257 (Sep. 25, 1987).
Maus et al., "Treatment of Intact Striatal Neurones with Cholera Toxin of 8-Bromoadenosine 3', 5'-(Cyclic) Phosphate Decreases the Ability of Pertussis Toxin to ADP-Ribosylate the .alpha.-Subunits of Inhibitory and Other Guanine-Nucleotide-Binding Regulatory Proteins, G.sub.i and G.sub.o --Evidence for Two Distinct Mechanisms," European J. Biochemistry, 196(2), 313-320 (Mar. 1, 1991).
Pinto et al., "Inhibition of the Self-Renewal Capacity of Blast Progenitors from Acute Myeloblastic Leukemia Patients by Site-Selective 8-Chloroadenosine 3',5'-Cyclic Monophosphate," Proc. Nat. Acad. Sci. USA, 89, 8884-8888 (Oct. 1992).
Wallach et al., "Hormonal Protection of Interferon-Treated Cells Against Double-Stranded RNA-Induced Cytolysis," FEBS Letters, 101(2), 364-368 (May 1979).
Bruynzeel et al., "Pentoxifylline Inhibits T-Cell Adherence to Keratinocytes," J. Invest. Dermatology, 104(6), 1004-1007 (Jun. 1995).
Durante et al., "Cyclic Nucleotide Regulation of Interleukin-1.beta. Induced Nitric Oxide Synthase Expression in Vascular Smooth Muscle Cells," Thrombosis Research, 75(1), 63-71 (1994).
Vallee et al., "Regulation of Guinea Pig Adrenal P450c21 Messenger RNA, Protein and Activity by RU486," J. Steroid Biochem. Mol. Biol., 54(1/2), 31-38 (Jul. 1995).
Novogrodsky et al., "Selective Suppression by Adherent Cells, Prostaglandin, and Cyclic AMP Analogues of Blastogenesis Induced by Different Mitogens," J. Immunology, 122(1), 1-7 (Jan. 1979).
Berkow et al., The Merck Manual of Diagnosis and Therapy, Merck and Co., Rahway, NJ, 1992, only pp. 338-342, 1305-1313, 1317-1320, 1337-1341 and 2435-2436 supplied.
Roth et al., "Complexing of Riboflavin and Its 2'-Substituted Analogs with Adenosine and Other 6-Substituted Purine Derivatives." Photochemistry and Photobiology, 6, 657-664 (1967).
Cottam Howard B.
Kini Ganesh D.
Ojo-Amaize Emmanuel A.
Brotman Harris F.
Crane L. Eric
Immune Modulation, Inc.
Kunz Gary L.
LandOfFree
Immunosuppression by administration of N.sup.6,N.sup.6 -disubsti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunosuppression by administration of N.sup.6,N.sup.6 -disubsti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunosuppression by administration of N.sup.6,N.sup.6 -disubsti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54729